The KINERET logo and generic name (anakinra)

KINERET Support Program
SCROLL DOWN FOR MORE INFORMATION ABOUT THE KINERET COPAY ASSISTANCE PROGRAM
Icon of money dropping into a hand

Financial Assistance and Reimbursement

Once enrolled,* Kineret ON TRACK® can provide information about potential programs and patient assistance options that may be available to you. These offerings include:

KINERET Copay Assistance Program†

KINERET Copay Assistance Program is for eligible patients who have commercial prescription insurance. Patients may pay as little as $0 per prescription and receive up to a maximum of $13,000 per calendar year.

Enroll now

KINERET Patient Assistance Program‡

Provides KINERET, at no cost, to patients who meet the Patient Assistance Program eligibility requirements.

KINERET QuickStart Program‡

Provides a limited supply of KINERET, at no cost, to eligible new patients experiencing an insurance-related delay in coverage.

KINERET Bridge Program‡

Provides a limited supply of KINERET, at no cost, to eligible patients experiencing a gap in coverage for KINERET.

Contact icon

There are 3 ways to get support from Kineret ON TRACK®:

Internet icon

Kineret ON TRACK® Secure Online Portal

Go online to complete the Patient Consent form and provide the necessary information. From there, you can access the Portal to check your eligibility for KINERET copay assistance or upload information requested by 
Kineret ON TRACK®.

Access online portal

Document icon

Prescription and Enrollment Form

To enroll in Kineret ON TRACK®, your doctor will need to complete the form, including all healthcare provider and patient signatures and fax it to 1-844-688-7624.

Download form

Phone icon

Call us

Call Kineret ON TRACK® at 1-866-547-0644 with questions or for help with potential program and patient assistance options.

Nurse icon

Injection Training and Support

Once enrolled* in Kineret ON TRACK®, and your healthcare provider has ordered injection training for you, our trained nurses are available to help you with injection training via telephone or video conference.

*You must enroll in the Kineret ON TRACK® program before accessing program support.

†In order to participate in the KINERET Copay Assistance Program (Program), a patient must have commercial prescription insurance for KINERET. The Program is not valid for patients whose prescriptions claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to Medicaid, Medicare, Medigap, Department of Defense (DOD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. This offer is not valid for cash paying patients. The Program is void where prohibited by law. Certain rules and restrictions apply. Sobi reserves the right to revoke, rescind, or amend this offer without notice. This Program is not insurance.
‡Program subject to eligibility requirement and program terms and conditions.

IMPORTANT SAFETY INFORMATION

INDICATIONS

KINERET® (anakinra) is a prescription medicine called an interleukin-1 receptor antagonist (IL-1Ra) used to:

RA: Reduce the signs and symptoms and slow the damage of moderate to severe active rheumatoid arthritis (RA) in people aged 18 years and older when 1 or more other drugs for RA have not worked

NOMID: Treat people with a form of Cryopyrin-Associated Periodic Syndromes (CAPS) called Neonatal-Onset Multisystem Inflammatory Disease (NOMID)

DIRA: Treat people with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)

KINERET is not for children with Juvenile Rheumatoid Arthritis.

IMPORTANT SAFETY INFORMATION

Do not take KINERET if you are allergic to:

  • Proteins made from bacteria called E. coli. Ask your healthcare provider if you are not sure
  • Anakinra or any of the ingredients in KINERET. See the end of the patient leaflet for a complete list of ingredients in KINERET

Before starting KINERET, tell your healthcare provider if you:

  • Have an infection, a history of infections that keep coming back, or other problems that can increase your risk of infections
  • Are scheduled to receive any vaccines. People using KINERET should not receive live vaccines
  • Have kidney problems
  • Are pregnant or plan to become pregnant. It is not known if KINERET will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if KINERET passes into your breast milk. You and your healthcare provider should decide if you will use KINERET or breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

KINERET and other medicines may affect each other and cause serious side effects.

KINERET may cause serious side effects, including:

Serious infections. KINERET may lower your ability to fight infections. Call your healthcare provider right away if you get an infection, have any sign of an infection including a fever or chills, or have any open sores on your body. Due to the risk of infection, you should not receive live vaccines while you use KINERET.

Serious allergic reactions. Stop using KINERET, call your healthcare provider, and get emergency help right away if you have any of these symptoms of a serious allergic reaction: swelling of your face, lips, mouth, or tongue; trouble breathing; wheezing; severe itching; skin rash, redness, or swelling outside of the injection site area; dizziness or fainting; fast heartbeat or pounding in your chest (tachycardia); or sweating. People with DIRA may have an increased risk of allergic reactions, especially in the first several weeks.

Decreased ability of your body to fight infections (immunosuppression). It is not known if treatment with medicines that cause immunosuppression, like KINERET, affect your risk of getting cancer.

Amyloidosis. KINERET may cause a buildup of abnormal proteins called amyloids around the injection site (a hard lump under the skin). Avoid using the same site to inject KINERET by rotating to alternating areas of the body. Your doctor may monitor you for amyloidosis.

Low white blood cell count (neutropenia). KINERET may cause you to have a lower number of certain white blood cells (neutrophils). Neutrophils are important in fighting infections. Your doctor should do blood tests to check your white blood cell level before starting and during the first year of treatment with KINERET.

The most common side effects of KINERET include:

  • Injection site skin reactions. The symptoms of injection site skin reactions may include: redness, swelling, bruising, itching, and stinging
  • RA gets worse with treatment, if you already have RA
  • Headache
  • Nausea and vomiting
  • Diarrhea
  • Joint pain
  • Fever
  • Feeling like you have the flu
  • Sore throat or runny nose
  • Sinus infection
  • Pain in your stomach area

Tell your healthcare provider if you have any side effect that bothers you or does not go away.

These are not all of the possible side effects of KINERET. For more information ask your healthcare provider or pharmacist. You can also see the Full Prescribing Information for KINERET including Patient Information and Instructions for Use at https://www.kineretrx.com/pdf/Full-Prescribing-Information-English.pdf

To report suspected side effects, contact Sobi North America at 1-866-773-5274 or FDA at 1-800-FDA-1088.

These are not all of the possible side effects of KINERET. For more information ask your healthcare provider or pharmacist. You can also see the Full Prescribing Information for KINERET including Patient Information and Instructions for Use at https://www.kineretrx.com/pdf/Full-Prescribing-Information-English.pdf

To report suspected side effects, contact Sobi North America at 1-866-773-5274 or FDA at 1-800-FDA-1088.

This information is intended for US healthcare professionals. Please confirm you are a healthcare professional to continue.